Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

About a third of Cuban adults have hypertension but most are under-treated leading to excess cardiovascular mortality, a new study in the Lancet Public Health has shown.

The Cuban health system’s focus on primary health care and preventative medicine has delivered substantial reductions in child and infant mortality, but premature death from the chronic disease of middle age remains high. Hypertension control in primary care has been given priority as a cost-effective means of addressing premature cardiovascular mortality in Cuba. However, there is little evidence from large-scale studies on the prevalence and management of hypertension in the country, and no direct evidence of the expected benefit of such efforts on cardiovascular mortality.

Researchers conducted a large prospective study of 150,000 adults, established by Dr Alfredo Dueñas Herrera in the late 1990s in collaboration with CTSU. A subset of participants were resurveyed in 2006-08 and all were followed up for mortality until 2016.

The study found that about a third of people in the study had hypertension, of whom two thirds had been previously diagnosed. Just over three quarters of those with diagnosed hypertension were being treated, the majority with only one hypertension medication. However, blood pressure was controlled in just a third of those receiving treatment. Uncontrolled hypertension was associated with an approximate doubling in risk of cardiovascular death and accounted for around 20% of premature cardiovascular deaths.

Professor Sarah Lewington said that although levels of hypertension diagnosis and treatment were comparable to those in some high-income countries, the proportion of people whose blood pressure was controlled was low. The under-treatment of hypertension might in part reflect the limited availability of blood pressure lowering medication, indeed the baseline survey was conducted immediately following a time of economic crisis in Cuba that began in 1991.

“As well as reducing hypertension prevalence, public health programmes in Cuba should aim to monitor and improve blood pressure control in people with diagnosed hypertension to prevent premature cardiovascular deaths”, said Dr Ben Lacey a public health consultant and co-author of the paper.

 

 

 

 

 

Similar stories

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Professor Barbara Casadei awarded 2022 Nylin Medal

The Swedish Society of Medicine has awarded the 2022 Nylin Medal to Professor Barbara Casadei, part of the Oxford BHF CRE leadership team.

Joaquim Vieira recognised in national image competition

DPAG BHF Intermediate Research Fellow Dr Joaquim Vieira has been shortlisted for the British Heart Foundation’s annual ‘Reflections of Research’ image competition.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.